NRSN News — Page 2
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2023-09-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-09-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-09-12 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-08-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-07-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-06-23 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-06-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-06-08 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-06-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-05-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-05-25 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-05-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-05-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-05-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-04-26 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-04-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-04-17 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-04-17 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-04-14 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-03-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-02-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-02-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-02-08 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-02-06 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-01-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2023-01-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K/A | NeuroSense Therapeutics Ltd. filed Form 6-K/A. |
| 2022-12-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-12-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-11-29 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-11-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-11-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-11-03 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-10-12 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-09-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-09-20 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-09-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-08-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-08-16 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-08-09 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-08-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-08-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-07-28 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-07-18 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-07-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-07-05 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-07-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-30 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-29 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-22 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-07 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-06-01 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-05-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-05-19 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-05-11 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-05-02 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-04-11 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-03-30 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-03-25 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-03-21 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-03-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-02-15 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-01-31 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-01-27 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-01-26 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2022-01-04 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |
| 2021-12-13 | Foreign issuer report | SEC filing | NeuroSense Therapeutics Ltd. filed Form 6-K | NeuroSense Therapeutics Ltd. filed Form 6-K. |